The largest database of trusted experimental protocols

7 protocols using sepharose cl 4b beads

1

IgG Purification Using Protein A

Check if the same lab product or an alternative is used in the 5 most similar protocols

Example 4

Culture supernatants were purified using protein A columns (GE Healthcare/cat#11-0034-95/according to manufacturer's instructions) and eluted in 0.1 M citrate buffer pH 3.0 and immediately neutralized in an equal volume of 1.0 M Tris-HCL pH 8.0 or directly rebuffered to PBS using a desalting column. Alternatively one could purify IgG using protein A beads (sepharose beads CL-4B, GE healthcare cat #170780-01)

+ Open protocol
+ Expand
2

IgG Purification using Protein A

Check if the same lab product or an alternative is used in the 5 most similar protocols

Example 4

Culture supernatants were purified using protein A columns (GE Healthcare/cat#11-0034-95/according to manufacturer's instructions) and eluted in 0.1 M citrate buffer pH 3.0 and immediately neutralized in an equal volume of 1.0 M Tris-HCL pH 8.0 or directly rebuffered to PBS using a desalting column. Alternatively one could purify IgG using protein A beads (sepharose beads CL-4B, GE healthcare cat #170780-01)

+ Open protocol
+ Expand
3

Protein A Purification of IgG

Check if the same lab product or an alternative is used in the 5 most similar protocols

Example 4

Culture supernatants were purified using protein A columns (GE Healthcare/cat #11-0034-95/according to manufacturer's instructions) and eluted in 0.1 M citrate buffer pH 3.0 and immediately neutralized in an equal volume of 1.0 M Tris-HCL pH 8.0 or directly rebuffered to PBS using a desalting column. Alternatively one could purify IgG using protein A beads (sepharose beads CL-4B, GE healthcare cat #170780-01)

+ Open protocol
+ Expand
4

IgG Glycopeptide Enrichment for Mass Spectrometry

Check if the same lab product or an alternative is used in the 5 most similar protocols
In the discovery phase, a total of 86 AIP, 115 PDAC patients, and 57 control individuals were analysed. The IgG purification and tryptic digestion from sera were modified from the method published by Selman et al. [18 (link)]. Briefly, IgG subclasses were captured using recombinant Protein A beads (TOSOH Corporation, Tokyo, Japan) from 2 μL of serum. Purified IgGs were digested with 20 μL of 0.02 μg/μL trypsin (Promega, Madison, WI, USA) at 37 °C overnight. Eight microliters of Sepharose Cl-4B beads (GE Healthcare, Uppsala, Sweden) was activated and sequentially conditioned with water and 83% acetonitrile (ACN). The IgG digests and beads were mixed and incubated in 83% ACN at room temperature for 30 min. The bead-captured IgG glycopeptides were washed twice in 83% ACN containing 0.1% trifluoroacetic acid (TFA) and twice sequentially in 83% ACN. The enriched glycopeptides were eluted with double-distilled water for MS analysis.
+ Open protocol
+ Expand
5

Antibody Characterization and Validation

Check if the same lab product or an alternative is used in the 5 most similar protocols
Commercial antibodies used were as follows: anti-FLAG (Sigma), anti-CDYL (Sigma, HPA035578; for Western blotting), anti-CDYL (Abcam, ab5188), anti-BrdU (Abcam, ab6326), anti-RPA1 (ABclonal, A0990), anti-RAD51 (ABclonal, A6268), anti-WRN (ABclonal, A6855), anti-DNA2L (Abcam, ab2179), anti-BLM (Abcam, ab96488), anti-MRE11 (Cell Signaling Technology, 4847), anti-NBS1 (Cell Signaling Technology, 14956), anti-RAD50 (Cell Signaling Technology, 3427), anti-Myc, anti-hemagglutinin (HA), anti–β-actin (MBL), anti-PanKac (PTM, 101), anti-PanKcr (PTM, 502; for Western blotting), and anti-PanKcr–conjugated agarose beads (PTM, 503; for immunoprecipitation). A CDYL antibody that we generated previously (peptide antigen: KQKESTLTRTNRTSPNN; B&M) was used for immunoprecipitation. The polyclonal antibodies against RPA1 K88cr, RPA1 K379cr, and RPA1 K595cr were generated by immunizing rabbits with two synthetic crotonyl peptides corresponding to residues surrounding K88, K379, and K595 of RPA1, respectively. HU, CPT, and VP16 were from Sigma. Streptavidin agarose resins were from Thermo Fisher Scientific. Protein A/G and Sepharose CL-4B beads were from GE Healthcare Biosciences, and protease inhibitor mixture cocktail was from Roche Applied Science.
+ Open protocol
+ Expand
6

Immunoprecipitation of BAX Interactors

Check if the same lab product or an alternative is used in the 5 most similar protocols
HCT116 BAX/BAK DKO cells were transfected with an empty cDNA3-mycBioID plasmid or cDNA3-mycBioID-BAX plasmids (wild-type, dC, 63–65A, dBH3) or YFP-tBid, YFP-Bim with and without BCL-xL plasmid as indicated. When stated, cells were treated with 25 µM CLZ (Sigma-Aldrich) or solvent control (DMSO) for 4 h. Cells were harvested and washed with PBS prior to lysis in immunoprecipitation (IP)–solubilization buffer (20 mM Tris, pH 7.4, 50 mM NaCl, 10% glycerol, and 0.1 mM EDTA) supplemented with 2% digitonin (MATRIX BioScience GmbH) and proteinase inhibitors. After 20 min incubation on ice, cells were passaged though a 1-mL syringe (Braun) with a 25G needle (Braun). The cell debris was cleared (15,000 × g, 10 min, 4 °C) and 2.5% of the supernatant were used as input. The lysis was incubated with washed protein A Sepharose cl-4B beads (GE Healthcare) and GFP antibody (Novus) or Myc beads (C-myc [9E10] Santa Cruz), at 4 °C overnight. The following day, the beads were washed five times with IP-solubilization buffer (20 mM Tris, pH 7.4, 50 mM NaCl, 10% glycerol, and 0.1 mM EDTA), supplemented with 0,02% digitonin and proteinase inhibitors after centrifugation at 350 × g, 3 min, and 4 °C. Beads were boiled in SDS sample buffer, and input and IP samples were analyzed by Western blot.
+ Open protocol
+ Expand
7

Comprehensive Molecular Profiling Protocol

Check if the same lab product or an alternative is used in the 5 most similar protocols
SYBR Green RT-qPCR gene expression analysis was done as described using primers from Table S2 [29 (link),30 (link)]. Immunoblotting and immunoprecipitations were performed as described [12 (link),17 (link)]. Briefly, cells were rinsed and scraped with cold PBS h containing protease and phosphatase inhibitor cocktails (EMD Chemicals, San Diego, CA, USA). Cells were extracted with EBC buffer (Boston BioProducts, Ashland, MA, USA) supplemented with protease and phosphatase inhibitors and 1.4 mM β-mercaptoethanol. Clarified extracts were incubated with 1 μg of capturing antibody and protein A Sepharose CL-4B beads (GE Healthcare, Chicago, IL, USA) overnight at 4 °C. The input extracts and immunoprecipitated samples were resolved using 4–20% gradient Criterion SDS-PAGE gels (BioRad, Hercules, CA, USA), and transferred to nitrocellulose membranes (GE Healthcare). Proteins were detected with commercial primary and secondary antibodies listed in Table S3, and with previously described antibodies against MuvB complex components LIN52 (12 kDa), LIN37 (40 kDa) and LIN9 (65 kDa) [12 (link),17 (link)].
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!